Cytology & Histology

Sin Hang Lee, M.D. graduated from Wuhan Medical College in China. After a residency-fellowship at Cornell-New York Hospital and Memorial Hospital for Cancer, Dr. Lee was certified by the American Board of Pathology and obtained the F.R.C.P. (C) degree by examination in 1966. He was on the faculty of McGill University and Yale University from 1968-2004 while practicing hospital-based pathology. Dr. Lee is currently the director of Milford Molecular Diagnostics, Milford, Connecticut. In the past 10 years, Dr. Lee has developed Sanger sequencing-based testing methods for HPV, Neisseria gonorrhoeae, Chlamydia trachomatis, Lyme disease borreliae and Ebolavirus implementable in community hospitals.

Dr. Lee has developed Sanger sequencing-based testing methods for HPV, Neisseria gonorrhoeae, Chlamydia trachomatis, Lyme disease borreliae and Ebolavirus implementable in community hospitals.

Irina Shabalova has got her MD degree in Moscow Medical Institute, PhD in 1986 from Cancer Research Centre by P.N.Herzen, Sc.D. degree in 2002. Her practice as clinical cytologist begins from 1975. Positions: Unior Researcher, P.A. Herzens’Cancer Research Centre, Associate Professor, Central Institute of Postgraduated Education, Senior Researcher, N.N. Blokhin Cancer Research Centre, 2003 - Professor, Russian Medical Academy of Postgraduated Education. She has published more than 140 papers, 9 books. An editorial board member of the journals “Clinical Laboratory Diagnostics”, “Laboratory” (Russia), advisory board member of the “Cytopathology” (GB). MIAC, president of the Russian Association of Clinical Cytologists.

Her research area includes clinical cytology

Dr. Kindelberger joined ConVerge in a full-time Pathology role in 2011, after having spent nearly 10 years at Brigham and Women's Hospital, beginning with his Residency in Anatomic Pathology in 2002. He next completed two clinical sub-specialty Fellowships: one in Cytopathology under the direction of Dr. Edmund Cibas, and the other in Women's and Perinatal Pathology under the direction of Dr. Christopher Crum. On completion of his training, Dr Kindelberger was appointed to the B & W's staff, serving in multiple roles, including Pathologist and Instructor in Pathology for Harvard Medical School. He has published significantly in the areas of gynecologic pathology, specifically ovarian carcinogenesis and trophoblastic disease pathology, with over 40 credited publications since 2003. Dr. Kindelberger received the Pier Paci Award for Excellence in Pathology Teaching in 2010, a testament to his willingness and ability to share his knowledge and expertise and colleagues to his students in the Harvard Medical School community. Dr. Kindelberger is board certified in both Anatomic Pathology and Cytopathology.

His recent research is related to circulating tumor cells in patients with metastatic cancers of the prostate, lung and breast.

Merce Jorda, M.D. is board certified in American Board of Pathology-Cytopathology. Has completed her fellowship from Jackson Memorial Hospital in Affiliation with the University Of Miami School Of Medicine. Prof. Jorda is the Medical Director, Clinical Laboratory Services -UMHC/SCCC and UM Hospital. Dr. Jorda’s research interests include molecular pathology of cancer and immunocytochemistry of tumors. She is interested in all markers, immunohistochemical and molecular, which may give the diagnostic, prognostic, predictive and treatment information. Dr. Jorda’s research interests have been basically at the level of anatomic pathology and cytopathology, specifically in the areas of breast and genitourinary tract malignancies as well as cytopathology.

Dr. Jorda's research interests include molecular pathology of cancer and immunocytochemistry of tumors. She is interested in all markers, immunohistochemical and molecular, which may give the diagnostic, prognostic, predictive and treatment information. Dr. Jorda's research interests have been basically at the level of anatomic pathology and cytopathology, specifically in the areas of breast and genitourinary tract malignancies as well as cytopathology.

Sahar Samaha, M.D. is board certified in AP/CP and Cytopathology. Has completed her residency and 2 fellowships in surgical pathology and cytopathology at University of Kansas Medical Center. She is in practice for over 15 years. She got her medical degree from Ain Shams University, Cairo, Egypt. Before moving to the united states, she finished her residency and obtained her master’s degree in Ophthalmology. She is the director of Aloha lab at Miraca life sciences.

Her research area includes surgical pathology and cytopathology

Dr. Li is an internationally recognized expert in the field of cytopathology and co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. Dr. Li also serves as editorial board members for several journals, committee member of the American Society of Cytopathology, and study sections of government agents and private organizations. She has more than 70 publications and book chapters. Dr. Li is also the editor of “Diagnostic Cytopathology Board Review and Self-Assessment”.

She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers

Kim Solez, M.D., FRCPC, Professor of Pathology at the University of Alberta, and President and CEO of Transpath Inc., is one of the world’s foremost kidney pathologists. He is the father of the Banff classification that sets standards worldwide for how biopsies from kidney and other solid organ transplants are interpreted, and started the post-earthquake disaster relief task force of the International Society of Nephrology. He is a popular blogger on internetevolution.com, and directs NKF cyberNephrology, a joint venture of the National Kidney Foundation (U.S.) and the University of Alberta. Kim has also created many educational videos for the Lifeboat Foundation.

Renal Pathology

James Michaelson PhD is the Director of the Laboratory of Quantitative Medicine, Member of the Departments of Pathology and Surgery at the Massachusetts General Hospital, and Associate Professor, Harvard University. His research concerns: the assembly of very large databases on patients; the development of improved mathematical methods for predicting cancer outcome; the analysis of patient outcome and cost; the analysis of cancer screening; the mathematics of growth; the mathematics of metastasis; the use of modern computer speech and telephony to design systems that improve patient compliance; and the development of advanced method for imaging cancer specimens.

Surgical Pathology

John DMedical Director. Cochran, MD, FCAP, is the Clinical Director of the Laboratory Accreditation Program at The Joint Commission. He completed college, medical school and residency training in Pathology at Emory University, Atlanta, Georgia. Dr. Cochran is Chief Executive Officer of Chestatee Pathology Associates, PC, a private practice in Pathology and Laboratory Medicine which employs 9 pathologists and owns, directs and/or operates multiple anatomic and clinical pathology labs in the metropolitan Atlanta area. His areas of interest include gastrointestinal and hepatic pathology, cytopathology, pediatric pathology, informatics, laboratory regulations, and practice management.

gastrointestinal and hepatic pathology, cytopathology

Maria Teresa Mascellino has completed her MD at the age of 25 years from University “La Sapienza” of Rome and specialization studies in Clinical Microbiology and Infectious Diseases from University “La Sapienza” of Rome. She is Director of Microbiology Laboratory in the Department of Infectious Diseases. She has published more than 80 papers in reputed journals and has been serving as an editorial board member of repute. She is member of many scientific societies and has participated in relevant International Research Projects.

Microbiology

Rajat Sethi received is currently the Chair of Department of Pharmaceutical and Biomedical Sciences, and Director of Research at the California Health Sciences University, Clovis, California. He received his Ph.D.from the Department of Medicine, University of Manitoba, Canada. Dr. Sethi. He has more than 100 publications in the field of cardiac pathology and toxicity, holds 22US and international patents, has authored/edited more than 9 books, written more than 22 chapters, editor for many journals , and serves in the editorial board for many journals.Dr. Sethi is the recipient of numerous federal and state grants and has also received funds from various foundations. He is the invited speaker in many national and international conferences. He has received many recognitions for his contribution to research and for promoting student scholarship.

Cardiac pathology

Dr.Richard Y. Zhao, a Molecular Pathologist, is a Tenured Professor of Pathology, Microbiology-Immunology and Human Virology at the University of Maryland School of Medicine. Dr. Zhao is also the Division Head of Molecular Pathology in the Department of Pathology, Director of Translational Genomics Laboratory in the School of Medicine, and Director of Molecular Diagnostics Laboratory at the University of Maryland Medical Center. Dr. Zhao’s clinical expertise is in the area of molecular pathology and personalized medicine. His basic science research interests are in HIV/AIDS, cancer biology and nanoparticle-based single molecule detections. Dr. Zhao has published over one hundred scientific papers and has served on numerous scientific editorial boards including Clinical and Applied Immunology Reviews, Clinical Laboratory Science, Cell Research, Cell and Biosciences, Chinese Journal of Clinical and Experimental Virology, Journal of Clinical and Experimental Pathology, Frontiers in Virology, Microbial Cell, PLoS One and Retrovirology. He has been invited to review scientific grant applications for funding agencies of over 10 different countries and has chaired a number of NIH grant review study panels. He has been invited to give scientific and clinical lectures world-wide.

Experimental Pathology

Dr. Alahari obtained his Bachelor of Science in Biology and Master of Science in Human Genetics from India in 1983 and 1986 respectively. His Ph.D. in Molecular Biology was awarded by Drexel University, Philadelphia in the year 1994. From 1994 to 1998, Dr. Alahari did a post-doctoral fellowship at the University of North Carolina at Chapel Hill. Since 1998, he has been a faculty member at the University of North Carolina and in 2004 joined the LSUHSC as Associate Professor of the Department of Biochemistry. During his tenure at the University of North Carolina, he discovered a novel protein that he termed, Nischarin. Dr. Alahari has published several papers describing the function of Nischarin. He has served on editorial review boards and study sections. In addition he availed visiting professorships at the University of Pennsylvania, Philadelphia and Rockefeller University, New York.

Molecular Biology

Wenqing Cao, MD is a gastrointestinal pathologist and assistant professor at University of Rochester Medical Center. She received her Medical Degree from Tongji Medical University, China. She completed Anatomic and Clinical Pathology residency at Northwester University and Gastrointestinal Pathology fellowship at the Mount Sinai Medical Center. Since 1998, Dr. Cao has done extensive basic and clinical translational research in GI malignancies. He has published more than 20 papers in reputed journals and has been serving as an editorial board member.

GI malignancies

Gabriela Oprea-Ilies has a medical degree from The Institute of Medicine and Pharmacy, Bucharest, Romania. She completed pathology residency at the University of Minnesota, Twin Cities and Cytology fellowship at Emory University, Atlanta, GA. She studied breast cancer with Dr. Schnitt, Collins and Mallory, in Boston. Currently she is a pathologist, Assistant Professor and Principal Investigator of the breast tissue bank at Emory University, Director of the Immunolab at Grady Memorial Hospital and Adjunct Professor at Georgia State University. She has published in reputed journals, has been reviewing papers and serving in the editorial board member of repute.

Pathology